SEI is priced at $0.068892, with the supplied 24-hour change showing a 4.97% gain. However, the reported current price is above the stated 24-hour high of $0.068212, so the price and range figures are inconsistent and should be treated cautiously.

The reported 24-hour low is $0.064936, making the stated range $0.003276, or about 5.0% of the low. The price has rebounded strongly within that stated range, but the high-price mismatch prevents a fully reliable reading of the day’s trading boundaries.

Reported 24-hour volume is 49,752,722, and volume-to-market-cap is 10.73%. These figures indicate meaningful trading activity relative to market capitalization, but without a comparison to prior volume they do not establish whether participation is unusually strong or weakening.

The hourly 8, 13, 21, and 55-period SMAs are $0.0675, $0.0671, $0.0666, and $0.0668, all below the current price. Their listed positive readings support near-term strength, while the 144-period SMA at $0.0700, with a negative 1.57% reading, is above price and points to a less favorable longer hourly trend.

The 1-hour RSI of 67 is consistent with strong short-term momentum and is approaching commonly watched overbought territory. In contrast, the 7-day RSI of 46 indicates that momentum over the broader weekly window is more subdued, rather than confirming a decisive trend reversal.

Returns across timeframes are mixed: SEI is up 4.97% over 24 hours but down 4.38% over seven days and 6.97% over 14 days. This suggests the daily move is a rebound against recent weakness, not yet evidence that the short-term decline has been reversed.

The 30-day change of positive 50.54% provides a significant counterpoint, showing substantial gains over the month despite the recent pullback. Still, the price remains roughly 94% below its $1.14 all-time high, a historical comparison that underscores the scale of the longer-term decline but does not alone determine the near-term outlook.

Overall, the strongest bullish evidence is the daily gain, price above the shorter hourly averages, and positive 30-day return. The main opposing evidence is the negative seven- and 14-day performance, the weekly RSI below 50, and price below the 144-period average; together these make the recovery look unconfirmed.

Rating: Hold. The short-term rebound and strong 30-day performance argue against a clear Sell, but the recent weekly losses and conflicting momentum readings are not enough to support a Buy; the inconsistent 24-hour high also reduces confidence in the price snapshot. The primary evidence for Hold is the balance between price strength above shorter hourly averages and continued weakness across seven- and 14-day returns, reinforced by the subdued weekly RSI and overhead 144-period average.